Olink Holding AB (OLK)
23.24
+0.08
(+0.37%)
USD |
NASDAQ |
May 07, 16:00
23.24
0.00 (0.00%)
After-Hours: 20:00
Olink Total Assets (Quarterly): 602.25M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 602.25M |
| September 30, 2023 | 552.82M |
| June 30, 2023 | 530.50M |
| March 31, 2023 | 559.90M |
| December 31, 2022 | 476.29M |
| September 30, 2022 | 438.16M |
| June 30, 2022 | 473.18M |
| Date | Value |
|---|---|
| March 31, 2022 | 516.31M |
| December 31, 2021 | 539.78M |
| September 30, 2021 | 552.59M |
| June 30, 2021 | 574.69M |
| March 31, 2021 | 570.87M |
| December 31, 2020 | 425.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
425.32M
Minimum
Dec 2020
602.25M
Maximum
Dec 2023
524.05M
Average
539.78M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Thermo Fisher Scientific Inc | 97.10B |
| Abliva AB | 8.692M |
| Karolinska Development AB | 118.29M |
| Calliditas Therapeutics AB | 184.69M |
| Oncopeptides AB | 27.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 99.55M |
| Shareholders Equity (Quarterly) | 502.70M |
| Current Ratio | 4.748 |